Dear interested parties,
The State Serum Institute welcomes the parties for 347964, Autogenous Vaccines DK.
If your company is interested in participating in the bidding, online registration in the web-based eSourcing system CTM (EU-Supply) is required. It is free to create a user account in the system, and once your company is registered, you will gain access to all of the State Serum Institute's bids, including future ones.
After registration, your company can log in and view the bidding material, including all questions/requirements that your company needs to respond to and fulfill, as well as the associated documents that need to be submitted as part of the overall and final proposal.
PARTICIPATION:
Follow the instructions below when your company wishes to participate in one of the State Serum Institute's tenders:
Log in to the system and click "Accept." Please note that by clicking "Accept," you are not obligated to submit a bid but have merely acknowledged that you have gained access to the available material.
By accepting, you will gain access to the relevant material. You can now answer the questions and provide tender material, as well as attach the documents specified in the tender.
Please be aware that bids must be submitted through the eSourcing system CTM (EU-Supply) before the deadline of 2023-11-28 12:00:00 local time. Otherwise, your proposal will not be considered.
OTHER INFORMATION:
All correspondence between potential suppliers and the State Serum Institute is conducted through EU-Supply.
Please note that both the actions of the State Serum Institute and the bidder are logged in the system.
For technical questions regarding the use of the system, please contact EU-Supply's Support at phone +45 70 20 80 14 (#) or email (mailto:support@eu-supply.com (mailto:support@eu-supply.com)).
Questions about the bidding itself should be directed to the State Serum Institute via the messaging module within EU-Supply.
Responses to these questions related to bidding will be published in the system and will be accessible to all.
Sincerely,
Susanne Pedersen
State Serum Institute